3654 results for «600»

Filter By

3654 results

PCR London Valves 2024 Closing Ceremony

26 Nov 2024 – From PCR London Valves 2024

Want to relive the best moments of PCR London Valves 2024? Don’t miss the Closing Ceremony!

We’ll revisit the key moments, from 'Meet the Masters' to groundbreaking insights, and thank all the incredible teams and contributors who made this event a success with a record-breaking 4066 participants...

PCR London Valves 2024 Closing Ceremony

TAVI - Advanced skills: overcoming challenges in transfemoral procedures

24 Nov 2024 – From PCR London Valves 2024

Discover how to master advanced techniques and navigate the most challenging situations in transfemoral TAVI procedures. This session will guide you through the potential pitfalls, teach you how to manage unanticipated scenarios and provide strategies for addressing complications during transcatheter heart valve (THV) deployment.

You’ll also dive...

TAVI - Advanced skills: overcoming challenges in transfemoral procedures

Meet the masters: TAVI

25 Nov 2024 – From PCR London Valves 2024

Dive into a lively session where TAVI experts share their wealth of experience to enhance your clinical practice. This video focuses on the practical aspects of the TAVI procedure, providing actionable insights you can apply right away.

Here’s what to expect:

  • Proven tips and tricks from highly experienced...
Meet the masters: TAVI

TAVI in bicuspid valves - Pushing the boundaries

24 Nov 2024 – From PCR London Valves 2024

Curious about the latest breakthroughs in TAVI for bicuspid aortic valve anatomy? This video dives into cutting-edge evidence from the NAVIGATE Bicuspid trial, BELIEVERS trial and the Notion 2 sub-analysis.

You'll also see a live demonstration of advanced TAVI sizing techniques and discover how Heart Teams are...

TAVI in bicuspid valves - Pushing the boundaries

Mitral TEER - Advanced skills (challenging anatomy - when, why and how?)

24 Nov 2024 – From PCR London Valves 2024

Curious about how to tackle complex mitral valve anatomies with transcatheter edge-to-edge repair (TEER)? This video dives straight into advanced techniques for challenging cases, delivering expert insights on expanding indications, optimal patient selection and precise procedural strategies.

Through real-world case presentations, you’ll learn the “when, why, and...

Mitral TEER - Advanced skills (challenging anatomy - when, why and how?)

Non-transfemoral TAVI - The toolkit

25 Nov 2024 – From PCR London Valves 2024

When should you consider alternative access for TAVI instead of the transfemoral route? This video dives right into the different non-transfemoral approaches, from transsubclavian to transcaval, and explains when each technique is most appropriate.

Learn how vascular modification can expand access options for more patients and discover...

Non-transfemoral TAVI - The toolkit

CTO PCI in images and case examples: what is new in 2026?

07 Jul 2026

Register for free to this webinar on Monday 31 August at 6:00pm with K. Mashayekhi, M. Ayoub and C. Ungureanu and learn to review the recent evidence on expected outcomes after CTO PCI, and much more!

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

The greatest advance in the next 40 years would be to remove the need for angioplasty

17 May 2017

Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...

Authors :

Spencer B. King
Spencer B. King

ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI

28 Mar 2026

Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide percutaneous coronary intervention

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase
The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]

A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial

03 Apr 2026

Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...

John Davies

Author

John Davies
Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Sarosh Khan

Author

Sarosh Khan
ORBITA-CTO: Chronic total occlusion PCI in stable angina

From PROTECT-AF to CHAMPION-AF: Where do we stand today?

01 Jul 2026

In this article, Jens Erik Nielsen-Kudsk reviews the evolution of left atrial appendage closure, from early trials such as PROTECT‑AF to recent evidence including CHAMPION‑AF, and discusses its expanding role in stroke prevention for atrial fibrillation.

Jens-Erik-Nielsen-Kudsk

Author

Jens Erik Nielsen-Kudsk
From PROTECT-AF to CHAMPION-AF: Where do we stand today?

COVID-19 vaccines: Burning questions from the community and real-world applicability

13 Jan 2021

View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.

COVID-19 vaccines: Burning questions from the community and real-world applicability
Didn’t find what you were looking for?